As of the latest SEC filings, REPLIGEN CORP (RGEN) is held by 535 institutional funds. The largest fund shareholder is iShares Core S&P Mid-Cap ETF (IJH), holding an estimated $206,414,984.64 in market value, representing 0.19% of its portfolio.
Funds holding REPLIGEN CORP (RGEN)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- RGEN
- CIK:
- 0000730272
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
IJH
iShares Core S&P Mid-Cap ETF
|
ETF | BlackRock / iShares | 0.19% | $206,414,984.64 | 1,751,952 | Mar 31, 2026 | May 26, 2026 |
|
VTI
VANGUARD TOTAL STOCK MARKET INDEX FUND
|
ETF | Vanguard | 0.01% | $201,176,825.26 | 1,707,493 | Mar 31, 2026 | May 28, 2026 |
|
NAESX
VANGUARD SMALL-CAP INDEX FUND
|
ETF | Vanguard | 0.09% | $145,378,451.46 | 1,233,903 | Mar 31, 2026 | May 28, 2026 |
|
PRJIX
T. Rowe Price New Horizons Fund, Inc.
|
MF | T. Rowe Price | 1.11% | $141,677,489.62 | 1,202,491 | Mar 31, 2026 | May 28, 2026 |
|
OTCIX
MFS Mid Cap Growth Fund
|
MF | Independent / Boutique | 0.81% | $111,526,522.80 | 866,360 | Feb 28, 2026 | Apr 22, 2026 |
|
BMGKX
BlackRock Mid-Cap Growth Equity Portfolio
|
MF | BlackRock / iShares | 1.55% | $91,488,282.27 | 710,699 | Feb 27, 2026 | Apr 24, 2026 |
|
PAWAX
T. Rowe Price All-Cap Opportunities Fund
|
MF | T. Rowe Price | 0.61% | $88,182,968.10 | 748,455 | Mar 31, 2026 | May 28, 2026 |
|
VISGX
VANGUARD SMALL-CAP GROWTH INDEX FUND
|
ETF | Vanguard | 0.21% | $81,259,393.62 | 689,691 | Mar 31, 2026 | May 28, 2026 |
|
FSMEX
Select Medical Technology and Devices Portfolio
|
MF | Fidelity | 1.90% | $69,514,200.00 | 540,000 | Feb 28, 2026 | Apr 24, 2026 |
|
VEMPX
VANGUARD EXTENDED MARKET INDEX FUND
|
ETF | Vanguard | 0.09% | $69,502,842.74 | 589,907 | Mar 31, 2026 | May 28, 2026 |
|
OTCFX
T. Rowe Price Small-Cap Stock Fund, Inc.
|
MF | T. Rowe Price | 0.77% | $61,986,515.84 | 526,112 | Mar 31, 2026 | May 28, 2026 |
|
WGROX
Wasatch Core Growth Fund
|
MF | Independent / Boutique | 1.97% | $58,737,747.16 | 498,538 | Mar 31, 2026 | May 5, 2026 |
|
CCALX
CONESTOGA SMALL CAP FUND
|
MF | Independent / Boutique | 2.56% | $57,629,885.70 | 489,135 | Mar 31, 2026 | May 29, 2026 |
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
ETF | First Trust | 2.51% | $56,958,076.06 | 483,433 | Mar 31, 2026 | May 28, 2026 |
|
FSPHX
Select Health Care Portfolio
|
MF | Fidelity | 0.89% | $55,096,440.00 | 428,000 | Feb 28, 2026 | Apr 24, 2026 |
|
CGOAX
Columbia Small Cap Growth Fund
|
MF | Columbia Threadneedle | 1.57% | $50,104,676.79 | 389,223 | Feb 28, 2026 | Apr 27, 2026 |
|
ODINX
Invesco Discovery Fund
|
MF | Invesco | 0.72% | $47,843,276.88 | 371,656 | Feb 28, 2026 | Apr 28, 2026 |
|
MDY
SPDR S&P MidCap 400 ETF Trust
|
ETF | State Street (SPDR) | 0.19% | $46,988,618.94 | 398,817 | Mar 31, 2026 | Jun 1, 2026 |
|
IBB
iShares Biotechnology ETF
|
ETF | BlackRock / iShares | 0.58% | $46,762,286.72 | 396,896 | Mar 31, 2026 | May 28, 2026 |
|
CSMVX
Congress Small Cap Growth Fund
|
MF | Independent / Boutique | 2.42% | $46,732,450.00 | 395,000 | Apr 30, 2026 | Jun 29, 2026 |
|
FCTDX
Strategic Advisers Fidelity U.S. Total Stock Fund
|
MF | Fidelity | 0.02% | $44,785,167.00 | 347,900 | Feb 28, 2026 | Apr 24, 2026 |
|
VEXPX
VANGUARD EXPLORER FUND
|
MF | Vanguard | 0.18% | $40,011,140.59 | 338,189 | Apr 30, 2026 | Jun 26, 2026 |
|
BBGSX
Bridge Builder Small/Mid Cap Growth Fund
|
MF | Independent / Boutique | 0.42% | $38,700,099.76 | 328,468 | Mar 31, 2026 | May 22, 2026 |
|
FSMAX
Fidelity Extended Market Index Fund
|
MF | Fidelity | 0.09% | $36,537,693.36 | 283,832 | Feb 28, 2026 | Apr 24, 2026 |
|
FSGAX
Franklin Small-Mid Cap Growth Fund
|
MF | Franklin Templeton | 0.99% | $35,070,041.75 | 296,425 | Apr 30, 2026 | Jun 24, 2026 |
Advertisement (320x50)